Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
Introduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not known whether poorly controlled diabetes increases...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-04-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/8/1/e001149.full |
id |
doaj-25ae4404afab4fd5a3d99eab60086ab1 |
---|---|
record_format |
Article |
spelling |
doaj-25ae4404afab4fd5a3d99eab60086ab12021-06-10T10:04:41ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972020-04-018110.1136/bmjdrc-2019-001149Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary reportHisashi Noma0Tsuyoshi OkuraYohei FujiokaRisa NakamuraMari AnnoYuichi ItoSonoko KitaoKazuhisa MatsumotoKyoko ShojiKeisuke SumiKazuhiko MatsuzawaShoichiro IzawaHiroko OkuraEtsuko UetaMasahiko KatoTakeshi ImamuraShin-Ichi TaniguchiKazuhiro Yamamoto13 Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan 3Division of Cardiolovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University, Yonago, JapanIntroduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not known whether poorly controlled diabetes increases HIC in patients with type 2 diabetes. We investigated whether HIC was increased in patients with poorly controlled diabetes, and whether HIC was associated with insulin resistance and incretins.Research design and methods We performed a meal tolerance test and the hyperinsulinemic–euglycemic clamp in 21 patients with type 2 diabetes. We calculated the postprandial C-peptide area under the curve (AUC)-to-insulin AUC ratio as the HIC; measured fasting and postprandial glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon levels and analyzed serum adiponectin and zinc transporter-8 (ZnT8) gene polymorphism.Results The HIC significantly correlated with glycated hemoglobin (HbA1c) (r_S=0.58, p<0.01). In patients with high HIC above the median of 6.5, the mean HbA1c was significantly higher compared with low HIC below the median. Homeostatic model assessment (HOMA)-beta (r_S=−0.77, p<0.01) and HOMA-IR (r_S=−0.66, p<0.005) were correlated with HIC. The M/I value in the clamp study was correlated with HIC. GLP-1-AUC and GIP-AUC were not correlated with HIC. Glucagon-AUC was negatively correlated with HIC, but there were no significant differences between the high and low HIC groups. Adiponectin was positively correlated with HIC. The ZnT8 gene polymorphism did not affect HIC.Conclusions These results suggest that HIC was increased in patients with high HbA1c type 2 diabetes, low insulin secretion, low insulin resistance and high adiponectin conditions.https://drc.bmj.com/content/8/1/e001149.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hisashi Noma Tsuyoshi Okura Yohei Fujioka Risa Nakamura Mari Anno Yuichi Ito Sonoko Kitao Kazuhisa Matsumoto Kyoko Shoji Keisuke Sumi Kazuhiko Matsuzawa Shoichiro Izawa Hiroko Okura Etsuko Ueta Masahiko Kato Takeshi Imamura Shin-Ichi Taniguchi Kazuhiro Yamamoto |
spellingShingle |
Hisashi Noma Tsuyoshi Okura Yohei Fujioka Risa Nakamura Mari Anno Yuichi Ito Sonoko Kitao Kazuhisa Matsumoto Kyoko Shoji Keisuke Sumi Kazuhiko Matsuzawa Shoichiro Izawa Hiroko Okura Etsuko Ueta Masahiko Kato Takeshi Imamura Shin-Ichi Taniguchi Kazuhiro Yamamoto Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report BMJ Open Diabetes Research & Care |
author_facet |
Hisashi Noma Tsuyoshi Okura Yohei Fujioka Risa Nakamura Mari Anno Yuichi Ito Sonoko Kitao Kazuhisa Matsumoto Kyoko Shoji Keisuke Sumi Kazuhiko Matsuzawa Shoichiro Izawa Hiroko Okura Etsuko Ueta Masahiko Kato Takeshi Imamura Shin-Ichi Taniguchi Kazuhiro Yamamoto |
author_sort |
Hisashi Noma |
title |
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report |
title_short |
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report |
title_full |
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report |
title_fullStr |
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report |
title_full_unstemmed |
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report |
title_sort |
hepatic insulin clearance is increased in patients with high hba1c type 2 diabetes: a preliminary report |
publisher |
BMJ Publishing Group |
series |
BMJ Open Diabetes Research & Care |
issn |
2052-4897 |
publishDate |
2020-04-01 |
description |
Introduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not known whether poorly controlled diabetes increases HIC in patients with type 2 diabetes. We investigated whether HIC was increased in patients with poorly controlled diabetes, and whether HIC was associated with insulin resistance and incretins.Research design and methods We performed a meal tolerance test and the hyperinsulinemic–euglycemic clamp in 21 patients with type 2 diabetes. We calculated the postprandial C-peptide area under the curve (AUC)-to-insulin AUC ratio as the HIC; measured fasting and postprandial glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon levels and analyzed serum adiponectin and zinc transporter-8 (ZnT8) gene polymorphism.Results The HIC significantly correlated with glycated hemoglobin (HbA1c) (r_S=0.58, p<0.01). In patients with high HIC above the median of 6.5, the mean HbA1c was significantly higher compared with low HIC below the median. Homeostatic model assessment (HOMA)-beta (r_S=−0.77, p<0.01) and HOMA-IR (r_S=−0.66, p<0.005) were correlated with HIC. The M/I value in the clamp study was correlated with HIC. GLP-1-AUC and GIP-AUC were not correlated with HIC. Glucagon-AUC was negatively correlated with HIC, but there were no significant differences between the high and low HIC groups. Adiponectin was positively correlated with HIC. The ZnT8 gene polymorphism did not affect HIC.Conclusions These results suggest that HIC was increased in patients with high HbA1c type 2 diabetes, low insulin secretion, low insulin resistance and high adiponectin conditions. |
url |
https://drc.bmj.com/content/8/1/e001149.full |
work_keys_str_mv |
AT hisashinoma hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT tsuyoshiokura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT yoheifujioka hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT risanakamura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT marianno hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT yuichiito hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT sonokokitao hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT kazuhisamatsumoto hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT kyokoshoji hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT keisukesumi hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT kazuhikomatsuzawa hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT shoichiroizawa hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT hirokookura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT etsukoueta hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT masahikokato hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT takeshiimamura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT shinichitaniguchi hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport AT kazuhiroyamamoto hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport |
_version_ |
1721385117091364864 |